BeiGene, Ltd. (BGNE)
USD 184.71
(0.49%)
USD 184.71
(0.49%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.23 Billion USD | 11.91% |
| 2022 | 1.99 Billion USD | -16.94% |
| 2021 | 2.4 Billion USD | 38.78% |
| 2020 | 1.73 Billion USD | 173.14% |
| 2019 | 633.93 Million USD | 27.8% |
| 2018 | 496.03 Million USD | 36.93% |
| 2017 | 362.24 Million USD | -10.74% |
| 2016 | 405.81 Million USD | 247.55% |
| 2015 | 116.76 Million USD | 319.22% |
| 2014 | 27.85 Million USD | -44.87% |
| 2013 | 50.52 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.31 Billion USD | 3.15% |
| 2024 Q1 | 2.27 Billion USD | 1.82% |
| 2023 Q3 | 1.76 Billion USD | -8.73% |
| 2023 Q4 | 2.23 Billion USD | 26.8% |
| 2023 FY | 2.23 Billion USD | 11.91% |
| 2023 Q1 | 1.79 Billion USD | -9.84% |
| 2023 Q2 | 1.93 Billion USD | 7.26% |
| 2022 Q3 | 2.07 Billion USD | -0.23% |
| 2022 Q2 | 2.07 Billion USD | -2.82% |
| 2022 Q1 | 2.13 Billion USD | -11.11% |
| 2022 FY | 1.99 Billion USD | -16.94% |
| 2022 Q4 | 1.99 Billion USD | -3.62% |
| 2021 Q2 | 1.91 Billion USD | 5.5% |
| 2021 Q4 | 2.4 Billion USD | 24.55% |
| 2021 FY | 2.4 Billion USD | 38.78% |
| 2021 Q1 | 1.81 Billion USD | 4.96% |
| 2021 Q3 | 1.92 Billion USD | 0.62% |
| 2020 Q1 | 1.24 Billion USD | 95.63% |
| 2020 FY | 1.73 Billion USD | 173.14% |
| 2020 Q4 | 1.73 Billion USD | 36.35% |
| 2020 Q3 | 1.26 Billion USD | -6.41% |
| 2020 Q2 | 1.35 Billion USD | 9.41% |
| 2019 Q3 | 586.83 Million USD | 1.34% |
| 2019 Q4 | 633.93 Million USD | 8.03% |
| 2019 FY | 633.93 Million USD | 27.8% |
| 2019 Q1 | 549.55 Million USD | 10.79% |
| 2019 Q2 | 579.05 Million USD | 5.37% |
| 2018 Q1 | 350.2 Million USD | -3.32% |
| 2018 FY | 496.03 Million USD | 36.93% |
| 2018 Q4 | 496.03 Million USD | 16.66% |
| 2018 Q3 | 425.19 Million USD | -0.47% |
| 2018 Q2 | 427.18 Million USD | 21.98% |
| 2017 Q3 | 284.57 Million USD | 39.63% |
| 2017 Q1 | 68.31 Million USD | -83.17% |
| 2017 FY | 362.24 Million USD | -10.74% |
| 2017 Q4 | 362.24 Million USD | 27.3% |
| 2017 Q2 | 203.8 Million USD | 198.34% |
| 2016 FY | 405.81 Million USD | 247.55% |
| 2016 Q4 | 405.81 Million USD | 752.67% |
| 2016 Q2 | 31.18 Million USD | 40.91% |
| 2016 Q1 | 22.12 Million USD | -81.05% |
| 2016 Q3 | 47.59 Million USD | 52.62% |
| 2015 Q4 | 116.76 Million USD | 228.63% |
| 2015 Q2 | 27.05 Million USD | 0.0% |
| 2015 FY | 116.76 Million USD | 319.22% |
| 2015 Q1 | - USD | -100.0% |
| 2015 Q3 | 35.53 Million USD | 31.34% |
| 2014 Q4 | 27.85 Million USD | 0.0% |
| 2014 FY | 27.85 Million USD | -44.87% |
| 2013 FY | 50.52 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -565.248% |
| Alkermes plc | 933.53 Million USD | -139.278% |
| Agenus Inc. | 462.29 Million USD | -383.186% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 44.853% |
| Aptorum Group Limited | 5.25 Million USD | -42392.968% |
| Ardelyx, Inc. | 130.76 Million USD | -1608.239% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -366.929% |
| Bicycle Therapeutics plc | 224.41 Million USD | -895.376% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -1615.493% |
| ChromaDex Corporation | 26.5 Million USD | -8326.679% |
| Chimerix, Inc. | 19.74 Million USD | -11212.96% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -6249.992% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -2978.182% |
| CRISPR Therapeutics AG | 346.76 Million USD | -544.161% |
| Precision BioSciences, Inc. | 140.92 Million USD | -1485.115% |
| Dyadic International, Inc. | 2.34 Million USD | -95332.595% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -13635.129% |
| Fortress Biotech, Inc. | 165.93 Million USD | -1246.124% |
| Lantern Pharma Inc. | 2.73 Million USD | -81432.966% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -3024.992% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -63201.731% |
| Incyte Corporation | 1.59 Billion USD | -40.287% |
| IO Biotech, Inc. | 17.55 Million USD | -12623.536% |
| Jaguar Health, Inc. | 45.86 Million USD | -4770.152% |
| Novavax, Inc. | 2.57 Billion USD | 13.161% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -6094.864% |
| Opthea Limited | 264.6 Million USD | -744.192% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -1608.97% |
| ContextLogic Inc. | 206 Million USD | -984.342% |
| MiMedx Group, Inc. | 96.33 Million USD | -2218.846% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -4551.501% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -63198.825% |
| NextCure, Inc. | 14.99 Million USD | -14794.606% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -55163.335% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -33354.306% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -4679.187% |
| Vaxcyte, Inc. | 167.44 Million USD | -1233.985% |
| PDS Biotechnology Corporation | 33.25 Million USD | -6616.182% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -849.665% |
| Pharming Group N.V. | 244.07 Million USD | -815.195% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -18636.319% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -1647.967% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -33707.321% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -33707.321% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -2609.769% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -33525.531% |
| Acelyrin, Inc. | 86.35 Million USD | -2486.759% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -171826.84% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -15434.766% |
| Summit Therapeutics Inc. | 125.25 Million USD | -1683.329% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -23465.186% |
| Senti Biosciences, Inc. | 52.57 Million USD | -4149.004% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -3147.807% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -1374.302% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -114099.591% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -167150.989% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -884.757% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -23746.952% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -882.103% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -351.709% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -20366.777% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -8019.458% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -18353.528% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -359.05% |
| Immix Biopharma, Inc. | 3.72 Million USD | -59918.115% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -5807.5% |
| MEI Pharma, Inc. | 8.35 Million USD | -26635.416% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -7598.583% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -542.656% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -1431.336% |
| Fortress Biotech, Inc. | 165.93 Million USD | -1246.124% |
| Precigen, Inc. | 41.64 Million USD | -5263.904% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -4373.751% |
| AlloVir, Inc. | 45.01 Million USD | -4862.221% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -1613.822% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -1521.004% |
| ImmuCell Corporation | 18.81 Million USD | -11772.129% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -7813.782% |
| Onconetix, Inc. | 23.18 Million USD | -9536.145% |
| PureTech Health plc | 125.58 Million USD | -1678.699% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -24858.034% |
| Elevation Oncology, Inc. | 34.28 Million USD | -6415.793% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -91259.673% |
| Seer, Inc. | 39.36 Million USD | -5574.442% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -3512.485% |
| Innoviva, Inc. | 568.55 Million USD | -292.883% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -8103.849% |
| ESSA Pharma Inc. | 3.49 Million USD | -63811.262% |
| GlycoMimetics, Inc. | 6.9 Million USD | -32263.374% |
| GT Biopharma, Inc. | 6.63 Million USD | -33576.225% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -744.867% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -720.364% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -2558.396% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -22753.939% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -8121.664% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -69146.782% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -2928.107% |
| Aptose Biosciences Inc. | 15.8 Million USD | -14029.839% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -20133.764% |
| Soligenix, Inc. | 7.27 Million USD | -30604.79% |
| Century Therapeutics, Inc. | 175.94 Million USD | -1169.598% |
| Kura Oncology, Inc. | 51.66 Million USD | -4223.766% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -1741.777% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -53946.552% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -33673.707% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -784.308% |
| Autolus Therapeutics plc | 263.9 Million USD | -746.413% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -21210.284% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -2413.751% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -4662.882% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -533.047% |
| GRI Bio, Inc. | 2.69 Million USD | -82723.285% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -275812.227% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -7084.536% |
| IGM Biosciences, Inc. | 220.17 Million USD | -914.522% |
| INmune Bio, Inc. | 18.86 Million USD | -11742.562% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -770.927% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -8284.355% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -82071.096% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -67996.429% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -3721.305% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -2222.969% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -743.766% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -171.405% |
| Verastem, Inc. | 71.18 Million USD | -3037.942% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -4442.346% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -5690.202% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -4464.996% |
| Histogen Inc. | 5.69 Million USD | -39109.128% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -50833.543% |
| Surrozen, Inc. | 8.14 Million USD | -27324.727% |
| Organovo Holdings, Inc. | 2.74 Million USD | -81186.172% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -711605.293% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -3872.52% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -13428.004% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -4271.062% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -270042.887% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -1662.67% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -20556.822% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -1380.389% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -85571.21% |
| Apollomics, Inc. | 14.15 Million USD | -15682.83% |
| Amarin Corporation plc | 279.58 Million USD | -698.944% |
| Mesoblast Limited | 188.79 Million USD | -1083.14% |
| Turnstone Biologics Corp. | 14.14 Million USD | -15688.408% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -1135.56% |
| Synaptogenix, Inc. | 5.52 Million USD | -40297.08% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -33500.241% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -1213.133% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -26003.7% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -127005.548% |
| Exelixis, Inc. | 678.44 Million USD | -229.245% |
| Better Therapeutics, Inc. | 23.84 Million USD | -9268.946% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -1261.657% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -275.919% |
| NLS Pharmaceutics AG | 10.68 Million USD | -20814.806% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -137478.344% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -5638.29% |
| Gritstone bio, Inc. | 125.91 Million USD | -1673.953% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -15120.387% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -43796.792% |
| Avid Bioservices, Inc. | 275.66 Million USD | -710.302% |
| Insmed Incorporated | 1.66 Billion USD | -34.42% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -28932.194% |
| MediWound Ltd. | 27.18 Million USD | -8116.221% |
| OmniAb, Inc. | 87.4 Million USD | -2455.771% |
| Alector, Inc. | 487.66 Million USD | -358.045% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -453.652% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -12023.441% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -5721.135% |
| Zai Lab Limited | 240.17 Million USD | -830.041% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -254.53% |
| Aura Biosciences, Inc. | 29.22 Million USD | -7542.741% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -2249.405% |
| Immunic, Inc. | 25.36 Million USD | -8705.361% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -3126.275% |
| Veracyte, Inc. | 93.71 Million USD | -2283.448% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -85265.806% |
| FibroGen, Inc. | 585.72 Million USD | -281.362% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -12750.164% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -341934.311% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -39397.137% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 70.825% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -27147.426% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -2558.523% |
| TG Therapeutics, Inc. | 169.08 Million USD | -1221.078% |
| Galecto, Inc. | 5.89 Million USD | -37785.753% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -26864.558% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 14.69% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -7650.135% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -17598.629% |
| XBiotech Inc. | 8.39 Million USD | -26501.691% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -15120.387% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -4100.346% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -515.177% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -8208.823% |
| Theravance Biopharma, Inc. | 169 Million USD | -1221.711% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | -83.757% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -346.368% |
| Vaxxinity, Inc. | 30.94 Million USD | -7118.666% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -129.694% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -36937.048% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -199.737% |
| NexImmune, Inc. | 5.08 Million USD | -43834.738% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -601348.596% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -72545.672% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 68.57% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -43239.755% |
| Scopus BioPharma Inc. | 7.45 Million USD | -29865.307% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -8395.261% |
| Ainos, Inc. | 7.39 Million USD | -30109.313% |
| Pluri Inc. | 34.11 Million USD | -6448.265% |
| Prothena Corporation plc | 135.01 Million USD | -1554.417% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -818.847% |
| Celularity Inc. | 102.92 Million USD | -2070.179% |
| Rallybio Corporation | 9.43 Million USD | -23572.573% |
| Cue Biopharma, Inc. | 24.44 Million USD | -9037.836% |
| MeiraGTx Holdings plc | 319.99 Million USD | -598.065% |
| Omeros Corporation | 403.25 Million USD | -453.933% |
| Humacyte, Inc. | 114.67 Million USD | -1847.857% |
| Immunocore Holdings plc | 228.15 Million USD | -879.034% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -45720.39% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -2810.795% |
| Blueprint Medicines Corporation | 918.64 Million USD | -143.157% |
| CalciMedica, Inc. | 4.02 Million USD | -55355.412% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -12699.358% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -1349.137% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -2502.916% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -704.104% |
| Pulmatrix, Inc. | 15.96 Million USD | -13893.259% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -14061.821% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -8978.046% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -790.619% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -4298.345% |
| Cytokinetics, Incorporated | 1.21 Billion USD | -84.51% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -6928.109% |
| Nutriband Inc. | 1.07 Million USD | -206935.375% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -20907.655% |
| Vor Biopharma Inc. | 59.1 Million USD | -3679.345% |
| Roivant Sciences Ltd. | 773.95 Million USD | -188.615% |
| Evogene Ltd. | 17.99 Million USD | -12316.587% |
| ProKidney Corp. | 29.21 Million USD | -7545.619% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -3003.327% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -316750.761% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | -18.255% |
| CorMedix Inc. | 11.91 Million USD | -18643.35% |
| BioLineRx Ltd. | 50.7 Million USD | -4305.633% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -1394.553% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -2425.688% |
| Atai Life Sciences N.V. | 49.16 Million USD | -4443.639% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -7070.397% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -12335.943% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -1692.214% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -39407.322% |
| MediciNova, Inc. | 3.89 Million USD | -57299.809% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -12120.275% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -148396.418% |
| GeoVax Labs, Inc. | 3.51 Million USD | -63360.782% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -462.289% |
| Biomea Fusion, Inc. | 30.69 Million USD | -7178.41% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 17.929% |
| Mereo BioPharma Group plc | 15.96 Million USD | -13894.136% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -7059.206% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -3706.394% |
| Absci Corporation | 58.3 Million USD | -3731.202% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -11626.921% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -6866.952% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -2927.164% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -2453.346% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -6514.581% |
| Allakos Inc. | 74.79 Million USD | -2886.568% |
| Imunon, Inc. | 8.53 Million USD | -26085.606% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -9827.31% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -1845.567% |
| BioAtla, Inc. | 48.98 Million USD | -4459.964% |
| NLS Pharmaceutics AG | 10.68 Million USD | -20814.806% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -80279.417% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -1610.318% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -15613.992% |
| XOMA Corporation | 145.58 Million USD | -1434.376% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -6535.212% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -3148.657% |
| aTyr Pharma, Inc. | 31.59 Million USD | -6969.481% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -3513.128% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -4867.739% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -4514.983% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -77730.801% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -27280.964% |
| Akari Therapeutics, Plc | 4.58 Million USD | -48629.145% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -12496.445% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | -35.423% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -552932.869% |
| UroGen Pharma Ltd. | 243.52 Million USD | -817.262% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -595.682% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -80787.093% |
| Orgenesis Inc. | 35.53 Million USD | -6186.039% |
| Entera Bio Ltd. | 1.37 Million USD | -161882.886% |
| GH Research PLC | 6.7 Million USD | -33234.487% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -32749.176% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -11765.208% |
| Xencor, Inc. | 283.55 Million USD | -687.753% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -74715.377% |
| Replimune Group, Inc. | 113.21 Million USD | -1873.028% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -59353.545% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -2057.581% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -552932.869% |
| Portage Biotech Inc. | 4.45 Million USD | -50096.494% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -148396.418% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -9590.863% |
| OncoCyte Corporation | 49.29 Million USD | -4431.105% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -53896.841% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -279998.911% |
| Purple Biotech Ltd. | 10 Million USD | -22226.277% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -38506.015% |
| scPharmaceuticals Inc. | 57.26 Million USD | -3800.987% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -17931.484% |
| HilleVax, Inc. | 78.9 Million USD | -2730.785% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -44132.554% |
| Tharimmune, Inc. | 1.81 Million USD | -122968.176% |
| Genprex, Inc. | 3.25 Million USD | -68541.709% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -8136.823% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -42561.268% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -1084241.748% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -622897.2% |
| OKYO Pharma Limited | 7.42 Million USD | -30000.935% |
| Savara Inc. | 37.19 Million USD | -5905.98% |
| Curis, Inc. | 57.61 Million USD | -3777.22% |
| Daré Bioscience, Inc. | 26.32 Million USD | -8383.693% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -5598.357% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -154591.413% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -10629.353% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -10392.085% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -751.284% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -10399.878% |
| Erasca, Inc. | 78.61 Million USD | -2741.516% |
| bluebird bio, Inc. | 424.62 Million USD | -426.052% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -340798.463% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | -18.184% |
| DBV Technologies S.A. | 42.8 Million USD | -5119.028% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -340798.463% |
| Moderna, Inc. | 4.57 Billion USD | 51.143% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -31833.438% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -134787.923% |
| Molecular Templates, Inc. | 31.17 Million USD | -7066.097% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -12985.788% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -279.822% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -1694.1% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -8041.357% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -6027.233% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -3914.998% |
| MacroGenics, Inc. | 154.2 Million USD | -1348.536% |
| RenovoRx, Inc. | 4.46 Million USD | -49916.659% |
| Adicet Bio, Inc. | 37.12 Million USD | -5917.629% |
| Prime Medicine, Inc. | 60.78 Million USD | -3575.13% |
| Aditxt, Inc. | 28.53 Million USD | -7729.029% |
| Adagene Inc. | 45.16 Million USD | -4845.266% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -1236054.753% |
| Quantum-Si incorporated | 26.63 Million USD | -8287.759% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -220.22% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -73319.541% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -1843.045% |
| SciSparc Ltd. | 1.59 Million USD | -139946.646% |
| Vericel Corporation | 127.7 Million USD | -1649.144% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -40039.92% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -2516.909% |
| Generation Bio Co. | 171.63 Million USD | -1201.488% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -19239.775% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -5239.925% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -783.958% |
| Invivyd, Inc. | 51.71 Million USD | -4219.502% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -2328.59% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -34237.553% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -2858.758% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -218680.02% |
| 2seventy bio, Inc. | 310.12 Million USD | -620.27% |
| ADMA Biologics, Inc. | 193.97 Million USD | -1051.557% |
| Clene Inc. | 38.95 Million USD | -5634.754% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -6082.029% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -769.242% |
| GeoVax Labs, Inc. | 3.51 Million USD | -63360.782% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -1074.03% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -18239.951% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -1026.322% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -18217.184% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -4542.897% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -4127.293% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -503.953% |
| Evaxion Biotech A/S | 17.61 Million USD | -12579.135% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -1288.031% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -1358.191% |
| Trevena, Inc. | 48.26 Million USD | -4528.37% |
| Surrozen, Inc. | 8.14 Million USD | -27324.727% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -10243.802% |
| Cingulate Inc. | 10.36 Million USD | -21459.435% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -81127.055% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -5889.875% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -62181.655% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -16886.646% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -604.205% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -8889.271% |
| Clearmind Medicine Inc. | 3.61 Million USD | -61776.428% |
| Kronos Bio, Inc. | 54.2 Million USD | -4021.223% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -4648.303% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -9714.457% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -11029.211% |
| Statera Biopharma, Inc. | 22.67 Million USD | -9750.5% |
| ImmunityBio, Inc. | 1.09 Billion USD | -104.858% |
| Korro Bio, Inc. | 51.75 Million USD | -4216.247% |
| Kineta, Inc. | 7.22 Million USD | -30829.715% |
| BioVie Inc. | 9.7 Million USD | -22923.233% |
| Codexis, Inc. | 49.94 Million USD | -4372.318% |
| Celularity Inc. | 102.92 Million USD | -2070.179% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -2220.845% |
| Celcuity Inc. | 51.45 Million USD | -4241.576% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -646998.154% |
| Cibus, Inc. | 206.11 Million USD | -983.726% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -5158.962% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -8380.747% |
| IN8bio, Inc. | 8.77 Million USD | -25364.478% |
| Kodiak Sciences Inc. | 213.59 Million USD | -945.804% |
| Annexon, Inc. | 47.11 Million USD | -4640.745% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -2394.661% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -2217.835% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -16217.803% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 14.199% |
| Eyenovia, Inc. | 19.78 Million USD | -11192.783% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -1161.389% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -28981.422% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -9169.032% |
| Arcellx, Inc. | 339.75 Million USD | -557.463% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -18674.113% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -809.727% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -23258.193% |
| Moolec Science SA | 13.94 Million USD | -15917.834% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -5076.455% |
| Geron Corporation | 146.12 Million USD | -1428.632% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -4320.454% |
| Royalty Pharma plc | 6.29 Billion USD | 64.53% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -5515.809% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -758629.102% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -90692.194% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -1080.9% |
| Humacyte, Inc. | 114.67 Million USD | -1847.857% |
| Structure Therapeutics Inc. | 29.05 Million USD | -7589.042% |
| 89bio, Inc. | 59.96 Million USD | -3625.204% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -8341.008% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -186667.893% |
| Genelux Corporation | 8.42 Million USD | -26429.026% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -32480.863% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -1538.615% |
| Notable Labs, Ltd. | 4.42 Million USD | -50357.285% |
| Liquidia Corporation | 73.13 Million USD | -2954.15% |
| Mustang Bio, Inc. | 17.61 Million USD | -12578.041% |
| Immunovant, Inc. | 48.95 Million USD | -4462.852% |
| Quantum-Si incorporated | 26.63 Million USD | -8287.759% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -5719.618% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -71886.594% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -2924.254% |
| Acasti Pharma Inc. | 11.55 Million USD | -19228.061% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -9780.444% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -82071.096% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -5957.282% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -163803.373% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -36542.782% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -8894.339% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -9534.852% |
| PepGen Inc. | 34.63 Million USD | -6350.128% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -18293.808% |
| United Therapeutics Corporation | 1.18 Billion USD | -88.948% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -31883.734% |
| Solid Biosciences Inc. | 38.45 Million USD | -5708.269% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -26003.7% |
| Immuneering Corporation | 12 Million USD | -18501.582% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -711605.293% |
| Silo Pharma, Inc. | 1.56 Million USD | -142242.873% |
| Belite Bio, Inc | 4.21 Million USD | -52945.452% |
| XOMA Corporation | 145.58 Million USD | -1434.376% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -91899.341% |
| Bionomics Limited | 10.15 Million USD | -21888.437% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -10293.858% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -9648.806% |
| uniQure N.V. | 624.01 Million USD | -257.961% |
| Cassava Sciences, Inc. | 14.19 Million USD | -15636.132% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -1236054.753% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -1212.546% |
| Forte Biosciences, Inc. | 3.66 Million USD | -60831.369% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -857110.179% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -33007.218% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -28981.422% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -12750.164% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -21036.866% |
| Altimmune, Inc. | 16.54 Million USD | -13404.286% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -261.619% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -9648.806% |
| Compugen Ltd. | 55.77 Million USD | -3904.92% |
| Peak Bio, Inc. | 20.75 Million USD | -10663.286% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -1922.165% |
| Benitec Biopharma Inc. | 4.96 Million USD | -44917.009% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -1315.168% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -2871.432% |
| Zura Bio Limited | 21.29 Million USD | -10391.001% |
| PolyPid Ltd. | 17.46 Million USD | -12687.635% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -1887.334% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -2871.432% |
| Instil Bio, Inc. | 99.8 Million USD | -2138.198% |
| argenx SE | 444.95 Million USD | -402.02% |
| Immunome, Inc. | 28.65 Million USD | -7694.487% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -26693.139% |
| Verona Pharma plc | 58.84 Million USD | -3696.237% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -15333.87% |
| Shattuck Labs, Inc. | 14.85 Million USD | -14932.936% |
| CervoMed Inc. | 2.59 Million USD | -85953.995% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -45729.791% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -17438.819% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -21103.075% |
| Moolec Science SA | 13.94 Million USD | -15917.834% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -95216.415% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -3917.865% |
| AnaptysBio, Inc. | 364.28 Million USD | -513.184% |
| Design Therapeutics, Inc. | 11.95 Million USD | -18583.038% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -17510.722% |
| NeurAxis, Inc. | 1.91 Million USD | -116682.478% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -5638.142% |
| Lumos Pharma, Inc. | 13.33 Million USD | -16653.499% |
| Achilles Therapeutics plc | 19.08 Million USD | -11602.96% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -15333.87% |
| 180 Life Sciences Corp. | 5.38 Million USD | -41363.845% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -9369.836% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -9714.457% |
| Nutriband Inc. | 1.07 Million USD | -206935.375% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -7200.294% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -15293.453% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -456.663% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -6778.773% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -17017.998% |
| Palisade Bio, Inc. | 2.73 Million USD | -81453.268% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -42423.206% |
| Beam Therapeutics Inc. | 478.38 Million USD | -366.934% |
| Neurogene Inc. | 36.54 Million USD | -6011.642% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -461.311% |
| AEON Biopharma, Inc. | 159.88 Million USD | -1297.059% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -4587.815% |
| Sesen Bio, Inc. | 30.98 Million USD | -7109.347% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -8504.229% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -29282.801% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -1041.191% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -1063.063% |
| Athira Pharma, Inc. | 30.05 Million USD | -7331.693% |
| Vaccinex, Inc. | 5.94 Million USD | -37492.46% |
| HCW Biologics Inc. | 15.05 Million USD | -14740.237% |
| XOMA Corporation | 145.58 Million USD | -1434.376% |
| Nektar Therapeutics | 267.04 Million USD | -736.464% |
| Arvinas, Inc. | 644.6 Million USD | -246.532% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -12496.445% |
| Merus N.V. | 102.15 Million USD | -2086.708% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -1426.303% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -2248.343% |
| Rezolute, Inc. | 11.73 Million USD | -18936.509% |
| Clene Inc. | 38.95 Million USD | -5634.754% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -78349.101% |
| BeyondSpring Inc. | 48.26 Million USD | -4527.699% |
| Synlogic, Inc. | 32.89 Million USD | -6690.527% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -15186.006% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -136604.039% |
| Peak Bio, Inc. | 20.75 Million USD | -10663.286% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -3419.98% |
| Krystal Biotech, Inc. | 39.71 Million USD | -5524.576% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -493.065% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -2143.413% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -516102.863% |
| MannKind Corporation | 721.36 Million USD | -209.655% |
| Ikena Oncology, Inc. | 22.33 Million USD | -9901.092% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -106982.646% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -2077.351% |
| Gossamer Bio, Inc. | 249.14 Million USD | -796.557% |
| CohBar, Inc. | 1.03 Million USD | -216005.058% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -20797.596% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -11626.921% |
| Legend Biotech Corporation | 589.93 Million USD | -278.644% |
| Mural Oncology plc | 37.92 Million USD | -5789.433% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -1584.116% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -97216.815% |
| Disc Medicine, Inc. | 22.87 Million USD | -9665.001% |
| Champions Oncology, Inc. | 28.03 Million USD | -7867.698% |
| REGENXBIO Inc. | 262.22 Million USD | -751.833% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -66393.3% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -17721.478% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -16530.48% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -10434.044% |
| Vaxart, Inc. | 34.02 Million USD | -6465.008% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -10855.491% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -7728.941% |
| Cellectis S.A. | 249.57 Million USD | -795.019% |
| Longeveron Inc. | 5.33 Million USD | -41753.925% |
| Repare Therapeutics Inc. | 41.81 Million USD | -5241.457% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 7.13% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -3600.212% |
| Revolution Medicines, Inc. | 262.39 Million USD | -751.284% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -105915.377% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -25795.479% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -18828.43% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -15806.459% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -103746.769% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 56.625% |
| Denali Therapeutics Inc. | 122.96 Million USD | -1716.598% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -40039.92% |
| Veru Inc. | 32.81 Million USD | -6707.558% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -32419.202% |
| Cingulate Inc. | 10.36 Million USD | -21459.435% |
| Passage Bio, Inc. | 39.26 Million USD | -5589.328% |
| Context Therapeutics Inc. | 4.19 Million USD | -53189.501% |
| Exicure, Inc. | 8.54 Million USD | -26028.717% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -7469.961% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -21202.155% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -10034.495% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -1270.513% |
| Nuvalent, Inc. | 31.82 Million USD | -6919.275% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -35012.779% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -3444.388% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -12309.689% |
| OmniAb, Inc. | 87.4 Million USD | -2455.771% |
| Anew Medical, Inc. | 8.24 Million USD | -27002.627% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -5733.891% |
| Lipocine Inc. | 2.63 Million USD | -84780.658% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -8402.375% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -5454.919% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -8284.355% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -2492.734% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -41257.971% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -2599.486% |
| Ocugen, Inc. | 23.98 Million USD | -9213.864% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -4713.377% |
| Q32 Bio Inc. | 233.12 Million USD | -858.162% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -24538.694% |
| Alumis Inc. Common Stock | 53.5 Million USD | -4075.066% |
| Equillium, Inc. | 27.95 Million USD | -7889.927% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -981.235% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -39599.253% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -36321.909% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -1319.819% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -3117.122% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -22295.217% |
| Dominari Holdings Inc. | 4.63 Million USD | -48092.967% |
| Edesa Biotech, Inc. | 1.84 Million USD | -121191.221% |
| vTv Therapeutics Inc. | 29.56 Million USD | -7454.855% |
| Bio-Techne Corporation | 744.34 Million USD | -200.097% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -1671.421% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -548.485% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -5405.222% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -7614.004% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -2318.519% |
| Nkarta, Inc. | 105.6 Million USD | -2015.288% |
| BioCardia, Inc. | 4.59 Million USD | -48565.447% |
| Iterum Therapeutics plc | 32.66 Million USD | -6738.969% |